Journal
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
Volume 49, Issue 1, Pages 376-382Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10803-018-3721-8
Keywords
Risk factor; Opioid; ASD; Developmental disorder; Pregnancy
Categories
Funding
- Centers for Disease Control and Prevention (CDC) [U10DD000180, U10DD000181, U10DD000182, U10DD000183, U10DD000184, U10DD000498]
- Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [T32HD007489, U54 HD090256]
Ask authors/readers for more resources
Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child's risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95% confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95% CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available